1 results match your criteria: "Amrita Institute of Medical Science and Research Centre Amrita Vishwa Vidyapeetham Kochi India.[Affiliation]"
Exceptional long term response to crizotinib in ROS 1-postive advanced non small cell lung cancer.
Respirol Case Rep
September 2024
Department of Medical Oncology, Amrita Institute of Medical Science and Research Centre Amrita Vishwa Vidyapeetham Kochi India.
Non-small-cell lung cancer (NSCLC) accounts for the majority of lung cancer cases worldwide, with a significant proportion of patients harbouring actionable oncogenic alterations. Among these alterations, the ROS1 rearrangement represents a distinct subset with therapeutic implications. Here, we present the case of a 52-year-old man diagnosed with advanced NSCLC harbouring the ROS1 fusion gene.
View Article and Find Full Text PDF